Lynnette C. Fallon - 03 Jun 2025 Form 4 Insider Report for ClearPoint Neuro, Inc. (CLPT)

Reporting relationship: Director
Issuer ticker: CLPT
Reported as of: 03 Jun 2025
Net transaction value: -$128,226
SEC form: 4
Accepted by SEC: 05 Jun 2025, 16:17:02 UTC
Prior SEC filing: 23 May 2025
Next SEC filing: 21 May 2026
Source filing: View source filing
Reporting owner signature: /s/ Danilo D'Alessandro, by Power of Attorney for Lynnette C. Fallon

Key filing fact

Lynnette C. Fallon filed Form 4 for ClearPoint Neuro, Inc. (CLPT) on 05 Jun 2025.

Key facts

This page summarizes Lynnette C. Fallon's Form 4 filing for ClearPoint Neuro, Inc. (CLPT).
2 reported transactions and 0 derivative rows are listed below.
Accepted by SEC: 05 Jun 2025, 16:17.

Change

Previous filing in this sequence was filed on 23 May 2025.
Current net transaction value: -$128,226.

Research use

This tells you what this filing adds before you inspect full transaction and derivative tables.
You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reporting Owners (1)

CIK 0001195654 Primary reporting owner

FALLON LYNNETTE C

Relationship: Director
Address: C/O CLEARPOINT NEURO, INC., 120 S. SIERRA AVE., SUITE 100, SOLANA BEACH
Signature: /s/ Danilo D'Alessandro, by Power of Attorney for Lynnette C. Fallon
Signature date: 05 Jun 2025

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

CLPT transaction

Common Stock

Sale

Transaction value: $112,770
Shares: -9,000
Change %: -18%
Price: $12.53
Shares after: 42,101
Date: 03 Jun 2025
Ownership: Direct
Footnotes: F1, F2

CLPT transaction

Common Stock

Sale

Transaction value: $15,456
Shares: -1,200
Change %: -2.9%
Price: $12.88
Shares after: 40,901
Date: 03 Jun 2025
Ownership: Direct
Footnotes: F1, F3

^* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 3 footnotes

Footnote F1

This sale of shares was made to cover the tax liability incident to the vesting of 21,903 shares on May 16, 2025 under a restricted stock unit granted to the director on May 16, 2024.

Footnote F2

Represents a weighted average sales price per share. The shares were sold at prices ranging from $11.84 to $12.81. The Reporting Person has provided to the issuer, and will provide to any security holder of the issuer or the SEC staff, upon request, information regarding the number of shares sold at each price within the range.

Footnote F3

Represents a weighted average sales price per share. The shares were sold at prices ranging from $12.84 to $12.92. The Reporting Person has provided to the issuer, and will provide to any security holder of the issuer or the SEC staff, upon request, information regarding the number of shares sold at each price within the range.